A carregar...
LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer
The efficacy of gemcitabine therapy is often insufficient for the treatment of pancreatic cancer. The current study demonstrated that LW6, a chemical inhibitor of hypoxia-inducible factor 1α, is a promising drug for enhancing the chemosensitivity to gemcitabine. LW6 monotherapy and the combination t...
Na minha lista:
| Publicado no: | J Adv Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514270/ https://ncbi.nlm.nih.gov/pubmed/31193017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jare.2019.04.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|